期刊文献+

孕妇孕中期产前筛查28450例随访分析 被引量:6

Follow-up analysis on prenatal screening in 28450 cases of middle period pregnancy
原文传递
导出
摘要 [目的]评价孕中期孕妇血清筛查在诊断胎儿21-三体综合征、18-三体综合征和神经管畸形中的作用。[方法]应用时间分辨荧光免疫技术检测孕中期(15~20周)孕妇血清中的二项指标(Free-β-hCG、AFP),结合孕妇的年龄、体重、孕周,用专用软件计算风险值。对筛查出的高风险孕妇经优生遗传咨询,行羊水穿刺和产前超声检查。[结果]在筛查的28 450孕妇中,检出高风险1 000例,阳性率为3.51%,其中21-三体高风险598例,18-三体高风险136例,神经管畸形高风险266例。自愿接受羊水穿刺的高风险孕妇中,检出21-三体综合征7例,18-三体综合征4例;产前超声检出无脑儿7例,脊柱裂2例。通过对所有筛查孕妇的随访共发现311例出生缺陷。[结论]通过产前筛查,结合产前诊断可以有效减少染色体病和神经管畸形患儿的出生,是降低出生缺陷有效的群体筛查方法。 [ Objective] To evaluate the function and value of prenatal screening in the diagnosis of 21-trisomy syndrome, 18 -trisomy syndrome and neural tube defect. [Methods] Serum samples were collected during middle period pregnancy( 15 -20 week) and free-β-human chorionic gonadot ropin (free- β-HCG) and alphafetoprotein(AFP) level were determined by time-resolved fluoroimmunoassay (TR-FIA, or DELFIA) method. In combination with gestational age, weight, and age, we evaluated the risk assess- ment with assessment software. The pregnant women found with high risk in screening by eugenic genetic counseling were examined by amniocentesis and prenatal ultrasound. [ Results ] Of the 28 450 pregnant women through prenatal screening, 1000 were found to have high risk, the positivity rate being 3.51%. The calculated results showed that 598 and 136 cases were with high risk of 21-trisomy syndrome and 18-trisomy syndrome in 28 540 test samples, respectively. Among high risk pregnant women who voluntarily accepted amnioeentesis, 7 and 4 eases were with high risk of 21 trisomy syndrome and 18 trisomy syndrome, respec- tively. Two cases of anencephalus and 7 cases of spina bifida were detected by prenatal ultrasound. Three hundred and eleven cases of birth defects were detected in the follow-up pregnant women by prenatal screen- ing. [ Conclusion] The results in this study indicate that prenatal screening of middle period serum of pregnant women combined with prenatal diagnosis can reduce the risk of birth defects incidence and is the effective screening method to reduce birth defect.
出处 《上海预防医学》 CAS 2013年第4期200-202,共3页 Shanghai Journal of Preventive Medicine
关键词 产前筛查 随访 21-三体征 神经管畸形 出生缺陷 Prenatal screening Follow-up Trisomy 21 syndrome Neural tube defect Birth defect
  • 相关文献

参考文献4

二级参考文献13

  • 1卓乐雯,廖灿,宋淑本,涂新枝.唐氏综合征产前筛查研究[J].中国实用妇科与产科杂志,2004,20(7):414-416. 被引量:48
  • 2何平亚,张甦,文革生,沈国松,邱惠麒,薛建英.孕中期妇女血清free-β-HCG/AFP产前筛查的应用分析[J].临床医学,2006,26(10):83-85. 被引量:8
  • 3Wald N J, Kennard A, Hackshaw A, et al. A prenatal screening for Down' s syndrome[J]. J Med Screen, 1997, 4(3): 181 -246.
  • 4Lam YH, Ghosh A, Tang MH, et al. Second trimester maternal serum screening alpha-fetoprotein and human chorionic ganodatrophin screening for Down's syndrome inHong Kong [ J]. Prenat Diagn, 1998,18 (6) : 585 -589.
  • 5Lawrence D,Carison DE.Prenatal diagnosis-when and how? N Engl J Med,1992,327 (9):636-638.
  • 6Goodbum SF,Yates JRW,Raggatt PR,et al.Second trimester maternal serum screening using hCG AFP age.Prenat Diagn,1991,11 (2):83 -101.
  • 7Haddow JE,Palomaki GE,Knight GJ,et al.Screening of maternal serum for fetal Down's syndrome in the first trimester.N Engl J Med,1998,338(14):955 -962.
  • 8Suzmori K,Tanemuta M,Murakami I,et al.A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.Prenat Diant,1997,17(9):861 -866.
  • 9Benn PA,Fang M,Egan JF,et al.Incorporation of inhibin-A in second -trimester screening for Down's syndrome.Obstet Gynecol,2003,101 (3):451 -454.
  • 10Wald NJ,Kennard A,Hackshaw A,et al.Antenatal screening for Down's syndrome.J Med Screen,1997,4 (3):181-246.

共引文献13

同被引文献40

  • 1孟梦.“单亲二倍体导致的NIFTY结果与核型分析结果不一致”的点评[J].中国产前诊断杂志(电子版),2013,5(1):49-50. 被引量:3
  • 2孙尚军,李君.3000例孕中期唐氏综合征神经管缺陷筛查分析及产前诊断[J].中国妇幼保健,2005,20(18):2329-2329. 被引量:14
  • 3段涛,杨慧霞主译.高危妊娠[M].第3版,北京:人民卫生出版社,2008:1366-1367.
  • 4谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 5Kagan KO,Wright D,Baker A,et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gyneco1,2008,31:618-624.
  • 6Miao ZY, Liu X, Shi TK, et al. First trimester, second trimester, and integrated screening for Down syndrome in China. J Med Screen, 2012,19:68-71.
  • 7Leung TY, Chan LW, Leung TN, et al. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gyneco1,2007,29 : 14-17.
  • 8Jackson JM,Crider KS,Cragan JD,et al.Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race ethnicity,and the effect on the preva lence of trisomy 21,Metropolitan Atlanta,1996—2005[J].Am J Med Genet,2014,164(1):70-76.
  • 9Kim YJ,Lee JE,Kim SH,et al.Maternal age-specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age[J].Obstet Gynecol Sci,2013,56(3):160-166.
  • 10Olivares AB,Bernal MJ,Ros G,et al.Quality of data on folic acid content in vegetables included in several Spanish Food Composition Tables and new data on their folate content[J].Nutr Hosp,2006,21(1):9.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部